Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tandem Mass Spectrometry | 11 | 2024 | 182 | 4.050 |
Why?
|
| Chromatography, Liquid | 6 | 2023 | 142 | 1.320 |
Why?
|
| Nanoparticles | 3 | 2022 | 318 | 1.270 |
Why?
|
| Rats | 16 | 2024 | 3483 | 1.120 |
Why?
|
| Reproducibility of Results | 9 | 2024 | 935 | 1.010 |
Why?
|
| Nanomedicine | 3 | 2021 | 35 | 0.990 |
Why?
|
| Griseofulvin | 1 | 2024 | 1 | 0.970 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 2024 | 421 | 0.970 |
Why?
|
| Copper Radioisotopes | 3 | 2012 | 8 | 0.890 |
Why?
|
| Gold | 6 | 2012 | 136 | 0.860 |
Why?
|
| Antineoplastic Agents | 3 | 2022 | 803 | 0.860 |
Why?
|
| Plasma | 1 | 2022 | 31 | 0.810 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2012 | 178 | 0.750 |
Why?
|
| Aminopyridines | 1 | 2020 | 15 | 0.750 |
Why?
|
| Oxyquinoline | 1 | 2020 | 5 | 0.730 |
Why?
|
| Animals | 24 | 2024 | 15081 | 0.730 |
Why?
|
| Mycophenolic Acid | 1 | 2019 | 7 | 0.720 |
Why?
|
| Tongue | 1 | 2019 | 11 | 0.710 |
Why?
|
| Communicable Diseases | 1 | 2020 | 45 | 0.690 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2024 | 1618 | 0.660 |
Why?
|
| Chloroquinolinols | 1 | 2018 | 3 | 0.660 |
Why?
|
| Tissue Distribution | 5 | 2020 | 207 | 0.630 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 433 | 0.610 |
Why?
|
| Anilides | 2 | 2017 | 28 | 0.540 |
Why?
|
| Cyclohexanes | 2 | 2017 | 30 | 0.530 |
Why?
|
| Nanoshells | 2 | 2012 | 2 | 0.520 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2014 | 71 | 0.520 |
Why?
|
| Itraconazole | 1 | 2013 | 12 | 0.470 |
Why?
|
| Nanospheres | 1 | 2013 | 7 | 0.470 |
Why?
|
| Polyglycolic Acid | 1 | 2013 | 37 | 0.460 |
Why?
|
| Positron-Emission Tomography | 2 | 2012 | 80 | 0.450 |
Why?
|
| Lactic Acid | 1 | 2013 | 95 | 0.440 |
Why?
|
| Head and Neck Neoplasms | 2 | 2012 | 78 | 0.440 |
Why?
|
| Drug Carriers | 1 | 2013 | 125 | 0.430 |
Why?
|
| Chromans | 1 | 2012 | 15 | 0.420 |
Why?
|
| Neoplasms | 1 | 2022 | 1103 | 0.420 |
Why?
|
| Antifungal Agents | 1 | 2013 | 148 | 0.410 |
Why?
|
| Linear Models | 3 | 2019 | 275 | 0.410 |
Why?
|
| Vitamin E | 1 | 2012 | 61 | 0.400 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2011 | 12 | 0.380 |
Why?
|
| Peptides, Cyclic | 1 | 2011 | 29 | 0.380 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 55 | 0.360 |
Why?
|
| Drug Delivery Systems | 2 | 2022 | 202 | 0.350 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1371 | 0.340 |
Why?
|
| Protein Binding | 4 | 2024 | 972 | 0.340 |
Why?
|
| Nanotechnology | 4 | 2005 | 153 | 0.330 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2024 | 132 | 0.320 |
Why?
|
| Gold Colloid | 3 | 2005 | 5 | 0.310 |
Why?
|
| Male | 10 | 2024 | 20025 | 0.310 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 183 | 0.300 |
Why?
|
| Sensitivity and Specificity | 3 | 2023 | 562 | 0.300 |
Why?
|
| Rats, Nude | 3 | 2012 | 6 | 0.300 |
Why?
|
| Scattering, Radiation | 1 | 2007 | 47 | 0.290 |
Why?
|
| Cell Line, Tumor | 6 | 2017 | 2231 | 0.290 |
Why?
|
| Peptides | 3 | 2005 | 320 | 0.290 |
Why?
|
| Light | 1 | 2007 | 187 | 0.270 |
Why?
|
| Drug Stability | 2 | 2018 | 116 | 0.260 |
Why?
|
| Mice | 6 | 2023 | 5913 | 0.250 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 259 | 0.250 |
Why?
|
| Glycosides | 1 | 2024 | 21 | 0.240 |
Why?
|
| 2,2'-Dipyridyl | 1 | 2003 | 6 | 0.240 |
Why?
|
| Injections, Intralesional | 2 | 2014 | 11 | 0.230 |
Why?
|
| Phenols | 1 | 2024 | 80 | 0.230 |
Why?
|
| Biological Availability | 2 | 2021 | 88 | 0.220 |
Why?
|
| Solubility | 2 | 2021 | 118 | 0.220 |
Why?
|
| Molecular Structure | 2 | 2024 | 492 | 0.210 |
Why?
|
| Injections, Intravenous | 2 | 2013 | 62 | 0.210 |
Why?
|
| Doxorubicin | 1 | 2022 | 84 | 0.200 |
Why?
|
| Microsomes, Liver | 1 | 2022 | 70 | 0.200 |
Why?
|
| Humans | 13 | 2022 | 37093 | 0.200 |
Why?
|
| Liposomes | 1 | 2022 | 118 | 0.200 |
Why?
|
| Hydrazones | 1 | 2020 | 5 | 0.190 |
Why?
|
| Transplantation, Heterologous | 2 | 2011 | 90 | 0.190 |
Why?
|
| Feasibility Studies | 2 | 2012 | 208 | 0.180 |
Why?
|
| Chemistry, Physical | 1 | 2020 | 45 | 0.180 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 64 | 0.180 |
Why?
|
| Thermodynamics | 1 | 2020 | 216 | 0.170 |
Why?
|
| Neutron Activation Analysis | 2 | 2010 | 2 | 0.170 |
Why?
|
| Heart | 1 | 2020 | 180 | 0.160 |
Why?
|
| Mice, SCID | 2 | 2017 | 150 | 0.160 |
Why?
|
| Kidney | 1 | 2020 | 337 | 0.150 |
Why?
|
| Serum Albumin, Bovine | 4 | 2004 | 51 | 0.140 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2017 | 28 | 0.140 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2017 | 43 | 0.140 |
Why?
|
| Particle Size | 3 | 2007 | 215 | 0.140 |
Why?
|
| Receptors, Androgen | 1 | 2017 | 126 | 0.140 |
Why?
|
| Cell Nucleus | 3 | 2017 | 366 | 0.130 |
Why?
|
| Pharmaceutical Solutions | 1 | 2014 | 5 | 0.130 |
Why?
|
| Proline | 1 | 2014 | 43 | 0.120 |
Why?
|
| Freeze Drying | 1 | 2013 | 27 | 0.120 |
Why?
|
| Pyrrolidinones | 1 | 2013 | 7 | 0.120 |
Why?
|
| Delayed-Action Preparations | 1 | 2013 | 60 | 0.110 |
Why?
|
| Solvents | 1 | 2013 | 99 | 0.110 |
Why?
|
| Esophageal Neoplasms | 1 | 2014 | 127 | 0.110 |
Why?
|
| Curcumin | 1 | 2013 | 74 | 0.110 |
Why?
|
| Tomography, Emission-Computed | 1 | 2011 | 7 | 0.100 |
Why?
|
| Hyperthermia, Induced | 1 | 2011 | 17 | 0.100 |
Why?
|
| Laser Therapy | 1 | 2011 | 30 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 214 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2014 | 1369 | 0.090 |
Why?
|
| Models, Animal | 1 | 2011 | 134 | 0.090 |
Why?
|
| Hot Temperature | 1 | 2011 | 128 | 0.090 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 122 | 0.090 |
Why?
|
| Mice, Nude | 1 | 2011 | 337 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 448 | 0.090 |
Why?
|
| Octoxynol | 1 | 2007 | 19 | 0.070 |
Why?
|
| Spectrophotometry | 2 | 2004 | 70 | 0.070 |
Why?
|
| Calibration | 1 | 2007 | 56 | 0.070 |
Why?
|
| Cattle | 2 | 2004 | 477 | 0.070 |
Why?
|
| Monosaccharides | 1 | 2024 | 11 | 0.060 |
Why?
|
| Nuclear Localization Signals | 1 | 2004 | 17 | 0.060 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2003 | 3 | 0.060 |
Why?
|
| Fluorescamine | 1 | 2003 | 3 | 0.060 |
Why?
|
| Flocculation | 1 | 2003 | 6 | 0.060 |
Why?
|
| Succinimides | 1 | 2003 | 10 | 0.060 |
Why?
|
| Rhodamines | 1 | 2003 | 21 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 1180 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2003 | 111 | 0.060 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2003 | 98 | 0.060 |
Why?
|
| Coordination Complexes | 1 | 2003 | 28 | 0.060 |
Why?
|
| Sulfhydryl Compounds | 1 | 2003 | 47 | 0.060 |
Why?
|
| Nanostructures | 1 | 2005 | 134 | 0.050 |
Why?
|
| Glutathione | 1 | 2003 | 179 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2003 | 102 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 208 | 0.050 |
Why?
|
| Glucuronidase | 1 | 2022 | 15 | 0.050 |
Why?
|
| Glucuronides | 1 | 2022 | 11 | 0.050 |
Why?
|
| Ligands | 1 | 2003 | 349 | 0.050 |
Why?
|
| Microsomes | 1 | 2022 | 52 | 0.050 |
Why?
|
| Kinetics | 1 | 2003 | 708 | 0.050 |
Why?
|
| Protein Transport | 2 | 2017 | 302 | 0.050 |
Why?
|
| Electron Transport | 1 | 2001 | 40 | 0.050 |
Why?
|
| Biosensing Techniques | 1 | 2001 | 86 | 0.040 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2017 | 11 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 172 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 173 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 213 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 893 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 689 | 0.030 |
Why?
|
| Polysorbates | 1 | 2013 | 10 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2013 | 20 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 252 | 0.030 |
Why?
|
| Hela Cells | 2 | 2005 | 366 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 84 | 0.030 |
Why?
|
| Female | 2 | 2014 | 20969 | 0.030 |
Why?
|
| Ethanol | 1 | 2013 | 192 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 807 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 336 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 19 | 0.020 |
Why?
|
| Polylysine | 1 | 2004 | 8 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 2004 | 26 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2004 | 59 | 0.020 |
Why?
|
| Gene Products, tat | 1 | 2004 | 35 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 96 | 0.010 |
Why?
|
| Metals | 1 | 2004 | 98 | 0.010 |
Why?
|
| Axons | 1 | 2004 | 108 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 307 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 286 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 408 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 502 | 0.010 |
Why?
|
| Enzymes, Immobilized | 1 | 2001 | 14 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2001 | 34 | 0.010 |
Why?
|
| Hippocampus | 1 | 2004 | 561 | 0.010 |
Why?
|
| Catalase | 1 | 2001 | 109 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 10129 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 1518 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1568 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 11712 | 0.010 |
Why?
|
| Neurons | 1 | 2004 | 1175 | 0.010 |
Why?
|